The immune system protects a host from foreign pathogens. In rare cases, the immune system can attack the cells of the host organism causing autoimmune diseases. We outline a computational framework that combines bioinformatics and network analysis with an emerging targets platform. The computational framework presented here can be used to find drug targets for autoimmune diseases. It can also be used to find existing drugs that can be repurposed to treat autoimmune diseases based on networks of interactions or similarities between different diseases. Information on which gene regions are associated with the disease (single nucleotide polymorphisms) can be used in gene therapy when that technique becomes viable. Our analysis also revealed immune cell subtypes that are implicated in these diseases. These immune cell subtypes can be selected for immunotherapy experiments. Finally, our analysis also reveals intra-cellular and protein-protein interaction networks and pathways that can be targeted with small molecule inhibitors. The downstream off-target effects of these inhibitors can also be determined from such a network analysis. In summary, our computational framework can be used to find novel therapeutics for autoimmune diseases and potentially even other dysfunctions.
Introduction
The immune system is tasked with protecting a host from external pathogens (Takutu et al., 2011; Jesmin et al., 2016) . It is trained to not recognize self (peptides that are expressed by normal cells in the body of the host). However, in some cases it erroneously recognizes and attacks normal cells in the host. These are called autoimmune diseases.
Insights from bioinformatics coupled with data from emerging curated repositories can lead to novel therapeutics that mayameliorate symptoms of these diseases and help patients lead a normal lifestyle (Zhang, 2016a, b This kind of information can be used to find novel drug targets.
IRF5 interaction network
We also constructed the network of interactions between interferon regulatory factor 5 (IRF5) and other factors (Fig. 2) We look at the mation can be e e We note that some of the genes (like ENSG00000128594) are associated with thyroid disease, which is observed in patients with systemic lupus erythematosus. Finally, one of the regulatory features (ENSR00000217801) is active in cell lines consisting of many immune system cells (like B cells, natural killer cells and macrophages), and normal cells like those found in the spleen and pancreas (full list available from Supplementary Information; filename: Mappings-Homo_sapiens_Variation_Mappings_rs2004640_ regulatory.csv). In the future, it may be possible to use therapeutics to specifically target these cells or sites.
Discussion
The immune system protects the host against foreign pathogens. In rare circumstances, it can harm cells of the host causing autoimmune diseases. We present a computational framework that combines bioinformatics and network analysis approaches with data from a novel platform. Our framework can be used to find novel IAEES www.iaees.org therapeutic strategies for autoimmune diseases. We show it using two autoimmune diseases: systemic lupus erythematosus and Sjogren disorder. The computational framework presented here can be used to find drug targets for autoimmune diseases. It can also be used to find existing drugs that can be repurposed to treat autoimmune diseases. For example, Sjogren is associated with other diseases (Fig. 5) . Association information of this nature can be used to repurpose existing drugs to treat these diseases.
Information on which gene regions are associated with the disease (single nucleotide polymorphisms in Table 3 ) can be used in gene therapy when these techniques become viable.
Our analysis also reveals intra-cellular and protein-protein interaction networks and pathways that can be targeted with small molecule inhibitors. The downstream off-target effects of these inhibitors can also be determined from such a network analysis (intra-cellular regulatory network for IRF5, Fig. 6 ).
Our framework also revealed immune cell subtypes and specific sites that are implicated in these diseases (associated with a regulatory feature: ENSR00000217801). These immune cell subtypes can be selected for immunotherapy experiments. In the future, it may also be possible to use therapeutics to specifically target these sites instead of using systemic drugs.
Our approach can be combined with infectious disease models (Banerjee, 2013; Banerjee, 2015a, b; Banerjee and Moses, 2010; Banerjee et al., 2016) . Population level approaches like ordinary differential equations are computationally tractable and can scale up to simulate host pathogen dynamics in large organisms (Banerjee and Moses, 2009 ). These can also be used to investigate the role of molecular mimicry in autoimmune diseases. Finally, hybrid modelling approaches can also be very useful in modelling these biological systems (Banerjee et al., 2015; Banerjee, 2015a Banerjee, , 2015b .
Our techniques can also be combined with data on auto-antibodies and design specific strategies to increase levels of certain classes of protective auto-reactive (immunoglobulin M) IgM antibodies (Fattal et al., 2010) . Our framework can also be used to find classes of T-regulatory cells that have a protective function in autoimmune diseases (Herwijnen et al., 2012) . Future work will also investigate linking drug target databases with curated repositories of natural substances such as polyphenol (found in green tea) that have also been known to recruit T-regulatory cells (Wong et al., 2011) . This may lead to novel natural compounds that have a protective function in autoimmune diseases. Finally, our framework can be extended to incorporate information on idyotypic networks of antibodies (antibodies that link to other antibodies) that may have a role in autoimmune diseases (Shoenfeld, 2004) .
In summary, we present a computational framework for combining bioinformatics with network approaches along with a novel repository can enable us to find new targets for diseases. We show this here for autoimmune diseases. Our code is freely available from a repository (https://bitbucket.org/neelsoumya/ autoimmune_targets_pipeline). Computational techniques like these can shed light on the immune system in disease and help find novel therapeutic strategies.
Supplementary Information
A full list of all drugs in use or development and single nucleotide polymorphisms for Sjogren disorder and systemic lupus erythematosus, along with all code is available online (https://bitbucket.org/neelsoumya/autoimmune_targets_pipeline).
